Meta-analysis of the Predictive Value of Lipid Metabolism in Children with Henoch-Schonlei Purpura
1. Department of Pediatrics,the First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou 450003,China
2. College of Pediatrics,Henan University of Traditional Chinese Medicine,Zhengzhou 450046,China
*Corresponding author:ZHANG Xia,Associate professor,Associate chief physician;E-mail:ardar123@sina.com
HAN Shanshan,DING Ying,DAI Yanlin, et al. Meta-analysis of the Predictive Value of Lipid Metabolism in Children with Henoch-Schonlei Purpura [J]. Chinese General Practice, 2021, 24(32): 4137-4144. DOI: 10.12114/j.issn.1007-9572.2021.01.219.
韩姗姗,丁樱,代彦林等. 脂质代谢异常对儿童过敏性紫癜肾损伤预测价值的Meta分析[J]. 中国全科医学, 2021, 24(32): 4137-4144. DOI: 10.12114/j.issn.1007-9572.2021.01.219.
[1]JENNETTE J C,FALK R J,BACON P A,et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides[J]. Arthritis Rheum,2013,65(1):1-11. DOI:10.1002/art.37715.
[2]RUPERTO N,OZEN S,PISTORIO A,et al. EULAR/PRINTO/PRES criteria for Henoch-Sch?nlein purpura,childhood polyarteritis nodosa,childhood Wegener granulomatosis and childhood Takayasu arteritis:Ankara 2008. Part I:overall methodology and clinical characterisation[J]. Ann Rheum Dis,2010,69(5):790-797. DOI:10.1136/ard.2009.116624.
[3]PIRAM M,MALDINI C,BISCARDI S,et al. Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis:a population-based study[J]. Rheumatology(Oxford),2017,56(8):1358-1366. DOI:10.1093/rheumatology/kex158.
[4]KAWASAKI Y,SUYAMA K,HASHIMOTO K,et al. Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein Purpura nephritis[J]. Clin Rheumatol,2011,30(4):529-535. DOI:10.1007/s10067-010-1572-6.
[5]BLUMAN J,GOLDMAN R D. Henoch-Sch?nlein Purpura in children:limited benefit of corticosteroids[J]. Can Fam Physician,2014,60(11):1007-1010.
[6]CHEN J Y,MAO J H. Henoch-Sch?nlein Purpura nephritis in children:incidence,pathogenesis and management[J]. World J Pediatr,2015,11(1):29-34. DOI:10.1007/s12519-014-0534-5.
[7]陈汉. 基于13 755例过敏性紫癜患儿的肾脏损害危险因素的系统评价及Meta分析[D]. 重庆:重庆医科大学,2017.
[8]杜川,李弢,董璇. 儿童过敏性紫癜早期肾损伤的危险因素分析[J]. 国际检验医学杂志,2017,38(15):2057-2059. DOI:10.3969/j.issn.1673-4130.2017.15.015.
DU C,LI T,DONG X. Risk factors of early renal damage in children with Henoch Schonlein Purpura[J]. International Journal of Laboratory Medicine,2017,38(15):2057-2059. DOI:10.3969/j.issn.1673-4130.2017.15.015.
[9]刘睿,张晓旭,陈光磊,等.紫癜性肾炎伴血脂异常临床及病理分析[J].中国中西医结合肾病杂志,2019,20(11):995-997. DOI:10.3969/j.issn.1009-587X.2019.11.018. https://d.wanfangdata.com.cn/periodical/zgzxyjhsbzz201911018.
[10]李新叶,代艳,陆元奉,等. 儿童紫癜性肾炎的危险因素研究[J]. 中国临床新医学,2019,12(6):630-633.
LI X Y,DAI Y,LU Y F,et al. Study on risk factors of Henoch-Schonlein Purpura nephritis in children[J]. Chin J New Clin Med,2019,12(6):630-633.
[11]OZEN S,RUPERTO N,DILLON M J,et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides[J]. Ann Rheum Dis,2006,65(7):936-941. DOI:10.1136/ard.2005.046300.
[12]江载芳,申昆玲,沈颖,等. 诸福棠实用儿科学[M].北京:人民卫生出版社,2015.
JIANG Z F,SHEN K L,SHEN Y,et al. Zhu Futang Practice of Pediatrics[M]. Beijing:People's Medical Publishing House,2015.
[13]中华医学会儿科学分会肾脏病学组. 儿童常见肾脏疾病诊治循证指南(二):紫癜性肾炎的诊治循证指南(试行)[J].中华儿科杂志,2009,47(12):911-913. DOI:10.3760/cma.j.issn.0578-1310.2009.12.007.
The Subspecialty Group of Nephrology Society of Pediatrics. Chinese Medical Association Evidence-based guidelines on diagnosis and treatment of childhood common renal diseases(Ⅱ):evidence-based guideline on diagnosis and treatment of Henoch-Schonlein purpura nephritis[J].Chinese Journal of Pediatrics,2009,47(12):911-913. DOI:10.3760/cma.j.issn.0578-1310.2009.12.007.
[14]STANG A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol,2010,25(9):603-605. DOI:10.1007/s10654-010-9491-z.
[15]MA D Q,LI Y,HAN Z G,et al. Analysis on kidney injury-related clinical risk factors and evaluation on the therapeutic effects of hemoperfusion in children with Henoch-Schonlein Purpura[J]. Eur Rev Med Pharmacol Sci,2017,21(17):3894-3899.
[16]WU J L,HE L G,BAI L,et al. Apolipoprotein M serum levels correlate with IgA vasculitis and IgA vasculitis nephritis[J]. Dis Markers,2019,2019:1825849. DOI:10.1155/2019/1825849.
[17]XU H,LI W,MAO J H,et al. Association between red blood cell distribution width and Henoch-Schonlein Purpura nephritis[J]. Medicine(Baltimore),2017,96(23):e7091. DOI:10.1097/MD.0000000000007091.
[18]曹婷婷,罗军. 小儿过敏性紫癜性肾炎临床特征及其相关危险因素探究[J].临床医药文献杂志,2019,6(18):51. https://wenku.baidu.com/view/f59472a70708763231126edb6f1aff00bed570dd?fr=xueshu.
[19]张霞,丁樱,于文静,等. 儿童过敏性紫癜肾脏损伤发生的相关因素分析[J]. 中医学报,2013,28(9):1361-1362. DOI:10.16368/j.issn.1674-8999.2013.09.079.
ZHANG X,DING Y,YU W J,et al. Analysis of children anaphylactoid Purpura with kidney injury[J]. China Journal of Chinese Medicine,2013,28(9):1361-1362. DOI:10.16368/j.issn.1674-8999.2013.09.079.
[20]高吉照,焦玉清,卢思广. 儿童过敏性紫癜肾脏损害的临床相关因素分析[J].南京医科大学学报(自然科学版),2007,27(4):312-316.
GAO J Z,JIAO Y Q,LU S G. Analysis of correlated factors of renal damage in Henoch-Schonlein purpura[J].Journal of Nanjing Medical University(Natural Sciences),2007,27(4):
312-316.
[21]古娜娜•托列提别克,罗琼,郭艳芳. 儿童紫癜性肾炎危险因素分析[J].新疆医科大学学报,2012,35(10):1400-1403,1407.
Gunana• Tuolietibieke,LUO Q,GUO Y F. The risk factor analysis of henoch-schonlein purpura nephritis in childhood Journal of Xinjiang Medical University[J].2012,35(10):1400-1403,1407.
[22]刘翠云,陆睿,郭佳琦. 探讨73例儿童过敏性紫癜肾损害的高危因素[J]. 宁夏医学杂志,2018,40(12):1158-1161. DOI:10.13621/j.1001-5949.2018.12.1158.
LIU C Y,LU R,GUOJIA Q. Risk factors of renal impairment in children with Henoch-Schonlein Purpura[J]. Ningxia Med J,2018,40(12):1158-1161. DOI:10.13621/j.1001-5949.2018.12.1158.
[23]刘红霞,李小玲. 儿童过敏性紫癜102例临床分析[J].海南医学,2015,26(11):1607-1609.
LIU H X,LI X L. Clinical analysis of 102 cases of children with Henoch-Schonlein purpura[J]. Hainan Medical Journal,2015,26(11):1607-1609.
[24]刘静,陆彪. 儿童过敏性紫癜肾脏损害危险因素Logistic回归分析[J].实用医学杂志,2011,27(17):3130-3132. DOI:10.3969/j.issn.1006-5725.2011.17.015.
LIU J,LU B. Logistic regression analysis of the risk factors for kidney damage in children with Henoch-Schonlein purpura[J]. The Journal of Practical Medicine,2011,27(17):3130-3132. DOI:10.3969/j.issn.1006-5725.2011.17.015.
[25]刘丽君. 92例过敏性紫癜患儿的临床特征及合并肾损害的危险因素分析[J]. 广西医科大学学报,2018,35(4):487-490. DOI:10.16190/j.cnki.45-1211/r.2018.04.016.
LIU L J. Analysis of clinical features and risk factors of renal injury in 92 children with Henoch Schonlein purpura[J].Journal of Guangxi Medical University,2018,35(4):487-490. DOI:10.16190/j.cnki.45-1211/r.2018.04.016.
[26]吴丽娟,张耀东. 影响过敏性紫癜患儿发生肾脏损害危险因素的Logistic回归分析[J].重庆医学,2013(22):2654-2656. DOI:10.3969/j.issn.1671-8348.2013.22.033. https://kns.cnki.net/KCMS/detail/detail.aspx?filename=CQYχ201322032&dbname=CJFD&dbcode=CJFQ.
[27]张菲菲. 过敏性紫癜患儿肾脏损伤相关临床危险因素分析[D]. 石家庄:河北医科大学,2014.
ZHANG F F. Clinical risk factors of renal injury in children with Henoch Schonlein purpura[D]. Shijiazhuang:Hebei Medical University,2014.
[28]张小华,朱小晖. 小儿过敏性紫癜性肾炎临床特征及其相关危险因素分析[J].检验医学与临床,2017,14(16):2473-2475. DOI:10.3969/j.issn.1672-9455.2017.16.056. https://wenku.baidu.com/view/6b16014e905f804d2b160b4e767f5acfa0c7836a?fr=xueshu.
[29]赵国晓,马宏,杨娜娜,等. 过敏性紫癜患儿早期肾损伤相关因素分析[J]. 世界最新医学信息文摘,2018,18(28):38-39,41. DOI:10.19613/j.cnki.1671-3141.2018.28.014. ZHAO G X,MA H,YANG N N,et al. Analysis of related factors of early renal injury in children with henoch schonlein Purpura[J]. World Latest Medicine Information,2018,18(28):38-39,41. DOI:10.19613/j.cnki.1671-3141.2018.28.014.
[30]ELS?E S,AHNSTR?M J,CHRISTOFFERSEN C,et al. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL[J]. Atherosclerosis,2012,221(1):91-97. DOI:10.1016/j.atherosclerosis.2011.11.031.
[31]LUO G H,ZHANG X Y,NILSSON-EHLE P,et al. Apolipoprotein M[J]. Lipids Health Dis,2004,3:21. DOI:10.1186/1476-511X-3-21.
[32]CHRISTOFFERSEN C,NIELSEN L B,AXLER O,et al. Isolation and characterization of human apolipoprotein M-containing lipoproteins[J]. J Lipid Res,2006,47(8):1833-1843. DOI:10.1194/jlr.M600055-JLR200.
[33]KHOVIDHUNKIT W,MEMON R A,FEINGOLD K R,et al. Infection and inflammation-induced proatherogenic changes of lipoproteins[J]. J Infect Dis,2000,181(Suppl 3):S462-472. DOI:10.1086/315611.
[34]CLIFTON P M,MACKINNON A M,BARTER P J. Effects of serum amyloid A protein(SAA)on composition,size,and density of high density lipoproteins in subjects with myocardial infarction[J]. J Lipid Res,1985,26(12):1389-1398.
[35]CHRISTENSEN P M,LIU C H,SWENDEMAN S L,et al. Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1[J]. FASEB J,2016,30(6):2351-2359. DOI:10.1096/fj.201500064.
[36]GALVANI S,SANSON M,BLAHO V A,et al. HDL-bound sphingosine 1-phosphate Acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation[J]. Sci Signal,2015,8(389):ra79. DOI:10.1126/scisignal.aaa2581.
[37]邓美慧,傅睿,郑卫民,等. 过敏性紫癜患儿尿液、血清NGAL的表达及意义[J].江西医药,2017,52(11):1120-1123. DOI:10.3969/j.issn.1006-2238.2017.11.004.
DENG M H,FU R,ZHENG W M,et al. Expression and significance of urine and serum NGAL with Henoch-Schonlein puroura in children[J]. Jiangxi Medical Journal,2017,52(11):1120-1123. DOI:10.3969/j.issn.1006-2238.2017.11.004.
[38]董自杰,李彦青,李雪,等. 尿液NGAL、血清CysC联合诊断在儿童急性肾损伤中应用价值[J].中国临床研究,2017,30(8):1110-1112. DOI:10.13429/j.cnki.cjcr.2017.08.032.http://qikan.cqvip.com/Qikan/Article/Detail?id=672979898.
[39]徐莲,刘健胜,于艳辉,等. 血清Cystain C、尿NGAL及尿损份分子1联合检测对儿童过敏性紫癜早期肾损伤的诊断效能[J]. 山东医药,2017,57(35):79-82. https://d.wanfangdata.com.cn/periodical/shandyy201735027.